P. O. Gee reports having consultancy agreements with Project Tech; reports receiving honoraria from APOLLO APOL1 Long-term Kidney Transplantation Outcomes Consortium Community Advisory Council, Bayer International, CareDX, Center for Disease Innovation Patient Advisory Board/Kidney Research Institute Patient Advisory Committee, Patient Family Advisors Network, Otsuka Pharmaceutical Advisory Board, and Vertex International; reports being a scientific advisor or member of APOLLO Community Advisory Council, End Stage Renal Disease Network 5 Medical Review Board, FDA MedTech Color Collaborative Steering Committee on Health Equity in Medical Devices, Health Technology Improvement Foundation Health Equity Advisory Board, NephCure and Health Education and Literacy Collaborative Health Equity Steering Committee, NephCure International/HEAL Collaborative Patient Advisory Board, Otsuka Pharmaceuticals Advisory Board, and University of Washington Center for Dialysis Innovation Patient Advisory Board and the Human Factors Working Group Member and Patient Family Centered-Care Partners Advisory Board; and reports other interests/relationships as American Association of Kidney Patients Ambassador, American Kidney Fund Ambassador and Kidney Health Coach, American Society of Nephrology Diabetic Kidney Disease Collaborative Task Force, Kidney Health Initiative Patient Family Partnership Council Member, Kidney Patient Advisory Council Member, Patient Family Engagement-Learning Action Network Subject Matter Expert, National Kidney Foundation Kidney Advisory Committee, Patient-Centered Outcomes Research Institute Ambassador, Patient Family Advisors Network Advisors Diversity, Equity, and Inclusion Workgroup, Quality Insights Renal Network 5 Patient Advisory Chair, and United Network for Organ Sharing Ambassador.